AngioDynamics, Inc. Operating Lease, Expense
AngioDynamics, Inc. (ANGO) reported Operating Lease, Expense of $2.35 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-07-14
- AngioDynamics, Inc. operating lease, expense for the quarter ending 2026-05-31 was $548.00K, a 14.24% decline year-over-year.
- AngioDynamics, Inc. operating lease, expense for the quarter ending 2026-02-28 was $542.00K, a 17.50% decline year-over-year.
- AngioDynamics, Inc. operating lease, expense for the quarter ending 2025-11-30 was $619.00K, a 5.64% decline year-over-year.
- AngioDynamics, Inc. operating lease, expense for the quarter ending 2025-08-31 was $638.00K, a 6.04% decline year-over-year.
- AngioDynamics, Inc. operating lease, expense for fiscal 2026 was $2.35M, a 10.90% decline from fiscal 2025.
- AngioDynamics, Inc. operating lease, expense for fiscal 2025 was $2.63M, a 3.26% increase from fiscal 2024.
- AngioDynamics, Inc. operating lease, expense for fiscal 2024 was $2.55M, a 5.38% decline from fiscal 2023.
- AngioDynamics, Inc. operating lease, expense for fiscal 2023 was $2.69M, a 3.85% decline from fiscal 2022.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|---|
| 2026-05-31 | $548.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $1.09M derived: sum of 2 quarters · filed 2026-07-14 | $1.71M derived: sum of 3 quarters · filed 2026-07-14 | $2.35M 10-K · filed 2026-07-14 | |
| 2026-02-28 | $542.00K 10-Q · filed 2026-04-02 | $1.16M derived: sum of 2 quarters · filed 2026-04-02 | $1.80M 10-Q · filed 2026-04-02 | $2.44M derived: sum of 4 quarters · filed 2026-07-14 | |
| 2025-11-30 | $619.00K 10-Q · filed 2026-01-06 | $1.26M 10-Q · filed 2026-01-06 | $1.90M derived: sum of 3 quarters · filed 2026-07-14 | $2.55M derived: sum of 4 quarters · filed 2026-07-14 | |
| 2025-08-31 | $638.00K 10-Q · filed 2025-10-02 | $1.28M derived: sum of 2 quarters · filed 2026-07-14 | $1.93M derived: sum of 3 quarters · filed 2026-07-14 | $2.59M derived: sum of 4 quarters · filed 2026-07-14 | |
| 2025-05-31 | $639.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $1.30M derived: sum of 2 quarters · filed 2026-07-14 | $1.95M derived: sum of 3 quarters · filed 2026-07-14 | $2.63M 10-K · filed 2026-07-14 | |
| 2025-02-28 | $657.00K 10-Q · filed 2026-04-02 | $1.31M derived: sum of 2 quarters · filed 2026-04-02 | $1.99M 10-Q · filed 2026-04-02 | $2.64M derived: sum of 4 quarters · filed 2026-07-14 | |
| 2024-11-30 | $656.00K 10-Q · filed 2026-01-06 | $1.34M 10-Q · filed 2026-01-06 | $1.98M derived: sum of 3 quarters · filed 2026-07-14 | $2.63M derived: sum of 4 quarters · filed 2026-07-14 | |
| 2024-08-31 | $679.00K 10-Q · filed 2025-10-02 | $1.32M derived: sum of 2 quarters · filed 2026-07-14 | $1.97M derived: sum of 3 quarters · filed 2026-07-14 | $2.60M derived: sum of 4 quarters · filed 2026-07-14 | |
| 2024-05-31 | $645.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $1.29M derived: sum of 2 quarters · filed 2026-07-14 | $1.92M derived: sum of 3 quarters · filed 2026-07-14 | $2.55M 10-K · filed 2026-07-14 | |
| 2024-02-29 | $650.00K 10-Q · filed 2025-04-02 | $1.28M derived: sum of 2 quarters · filed 2025-04-02 | $1.90M 10-Q · filed 2025-04-02 | $2.55M derived: sum of 4 quarters · filed 2025-07-18 | |
| 2023-11-30 | $627.00K 10-Q · filed 2025-01-08 | $1.25M 10-Q · filed 2025-01-08 | $1.90M derived: sum of 3 quarters · filed 2025-07-18 | $2.60M derived: sum of 4 quarters · filed 2025-07-18 | |
| 2023-08-31 | $627.00K 10-Q · filed 2024-10-03 | $1.28M derived: sum of 2 quarters · filed 2025-07-18 | $1.97M derived: sum of 3 quarters · filed 2025-07-18 | $2.65M derived: sum of 4 quarters · filed 2025-07-18 | |
| 2023-05-31 | $650.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-18 | $1.35M derived: sum of 2 quarters · filed 2025-07-18 | $2.03M derived: sum of 3 quarters · filed 2025-07-18 | $2.69M 10-K · filed 2025-07-18 | |
| 2023-02-28 | $696.00K 10-Q · filed 2024-04-09 | $1.38M derived: sum of 2 quarters · filed 2024-04-09 | $2.04M 10-Q · filed 2024-04-09 | $2.73M derived: sum of 4 quarters · filed 2024-07-25 | |
| 2022-11-30 | $680.00K 10-Q · filed 2024-01-08 | $1.35M 10-Q · filed 2024-01-08 | $2.04M derived: sum of 3 quarters · filed 2024-07-25 | $2.72M derived: sum of 4 quarters · filed 2024-07-25 | |
| 2022-08-31 | $669.00K 10-Q · filed 2023-10-05 | $1.36M derived: sum of 2 quarters · filed 2024-07-25 | $2.04M derived: sum of 3 quarters · filed 2024-07-25 | $2.78M derived: sum of 4 quarters · filed 2024-07-25 | |
| 2022-05-31 | $688.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-25 | $1.37M derived: sum of 2 quarters · filed 2024-07-25 | $2.12M derived: sum of 3 quarters · filed 2024-07-25 | $2.80M 10-K · filed 2024-07-25 | |
| 2022-02-28 | $684.00K 10-Q · filed 2023-03-31 | $1.43M derived: sum of 2 quarters · filed 2023-03-31 | $2.11M 10-Q · filed 2023-03-31 | $2.90M derived: sum of 4 quarters · filed 2023-03-31 | |
| 2021-11-30 | $743.00K 10-Q · filed 2023-01-06 | $1.43M 10-Q · filed 2023-01-06 | $2.22M derived: sum of 3 quarters · filed 2023-01-06 | $3.02M derived: sum of 4 quarters · filed 2023-01-06 | |
| 2021-08-31 | $687.00K 10-Q · filed 2022-10-11 | $1.48M derived: sum of 2 quarters · filed 2022-10-11 | $2.27M derived: sum of 3 quarters · filed 2022-10-11 | $3.01M derived: sum of 4 quarters · filed 2022-10-11 | |
| 2021-05-31 | $791.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | $1.58M derived: sum of 2 quarters · filed 2022-07-22 | $2.32M derived: sum of 3 quarters · filed 2022-07-22 | $3.21M 10-K · filed 2022-07-22 | |
| 2021-02-28 | $794.00K 10-Q · filed 2022-04-07 | $1.53M derived: sum of 2 quarters · filed 2022-04-07 | $2.42M 10-Q · filed 2022-04-07 | $5.82M derived: sum of 4 quarters · filed 2022-04-07 | |
| 2020-11-30 | $737.00K 10-Q · filed 2022-01-07 | $1.62M 10-Q · filed 2022-01-07 | $5.02M derived: sum of 3 quarters · filed 2022-01-07 | $5.95M derived: sum of 4 quarters · filed 2022-01-07 | |
| 2020-08-31 | $884.00K 10-Q · filed 2021-09-30 | $4.28M derived: sum of 2 quarters · filed 2021-09-30 | $5.21M derived: sum of 3 quarters · filed 2021-09-30 | $6.11M derived: sum of 4 quarters · filed 2021-09-30 | |
| 2020-05-31 | $3.40M 10-K · filed 2020-08-10 | $4.33M derived: sum of 2 quarters · filed 2021-03-31 | $5.23M derived: sum of 3 quarters · filed 2021-03-31 | $3.35M 10-K · filed 2021-07-27 | |
| 2020-02-29 | $925.00K 10-Q · filed 2021-03-31 | $1.83M derived: sum of 2 quarters · filed 2021-03-31 | $2.47M 10-Q · filed 2021-03-31 | ||
| 2019-11-30 | $904.00K 10-Q · filed 2021-01-08 | $1.54M 10-Q · filed 2021-01-08 | |||
| 2019-08-31 | $640.00K 10-Q · filed 2020-10-07 | $700.00K 10-Q · filed 2019-10-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |